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ABSTRACT
This report describes a new PCR-based assay for the detection of Pseudomonas aeruginosa genotype D in
occupational saturation diving systems in the North Sea. This genotype has persisted in these systems
for 11 years (1993–2003) and represents 18% of isolates from infections analysed during this period. The
new PCR assay was based on sequences obtained after randomly amplified polymorphic DNA (RAPD)-
PCR analysis of a group of isolates related to diving that had been identified previously by pulsed-field
gel electrophoresis (PFGE). The primer set for the D genotype targets a gene that codes for a hypothetical
class 4 protein in the P. aeruginosa PAO1 genome. A primer set able to detect P. aeruginosa at the species
level was also designed, based on the 23S-5S rDNA spacer region. The two assays produced 382-bp and
192-bp amplicons, respectively. The PCR assay was evaluated by analysing 100 P. aeruginosa isolates
related to diving, representing 28 PFGE genotypes, and 38 clinical and community P. aeruginosa isolates
and strains from other species. The assay identified all of the genotype D isolates tested. Two additional
diving-relevant genotypes (TP2 and TP27) were also identified, as well as three isolates of non-diving
origin. It was concluded that the new PCR assay is a useful tool for early detection and prevention of
infections with the D genotype.
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INTRODUCTION
Saturation diving is used regularly during the
maintenance and inspection of offshore subsea
petroleum production systems in the North Sea.
The working and living environment of the divers
is unique, in that they are chronically exposed to
hyperbaric, warm and humid surroundings that
are capable of maintaining a rich microbial flora
[1–5]. Exposure to such hyperbaric environments
has been associated with a risk of acquiring
various conditions, including decompression
sickness, arterial gas embolism, neurological
symptoms and pulmonary dysfunctions [6]. How-
ever, the medical problems encountered most
frequently by divers are ear, nose and throat
complications [7]. Of these, acute infection of the
outer ear has been a well-known and frequent
problem associated with saturation diving since
the introduction of the technique in the late 1960s.
Outbreaks of infection involving several divers
have been a frequent cause of costly interruptions
in operations in both the USA and the UK [8,9].
A specific cause of these outbreaks is
Pseudomonas aeruginosa, which has also long been
known as the predominant bacterial pathogen in
‘swimmer’s ear’ [10]. P. aeruginosa is a common
bacterium that occurs worldwide in both fresh
and seawater, in soil and on plants. The organism
is characterised by its metabolic versatility and its
exceptional ability to adapt to and colonise
various ecological niches [11]. P. aeruginosa is a
well-known opportunistic pathogen and is of
growing importance in both hospital and com-
munity-acquired infections [12].
Field research on the presence of P. aeruginosa
in infections and the environment has been
continuous since the 1980s during the
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exploration of the Norwegian petroleum sector.
Systematic analysis of isolates by biotyping and
pulsed-field gel electrophoresis (PFGE) during
an 18-year survey has produced evidence of the
involvement of specific P. aeruginosa genotypes
in skin infections among occupational saturation
divers in the Norwegian sector [3–5]. Some P.
aeruginosa genotypes have been detected more
frequently than others in single infections and
recorded outbreaks [3,4]. These genotypes have
been shown to persist in saturation diving
systems for years, despite the fact that new
genotypes are being introduced continuously
[4,5]. Genotype D, which is the most prominent
of these genotypes, has been isolated from
single, recurrent and clusters of infections
involving several different genotypes and divers
[4].
For efficient control and prevention of P. aeru-
ginosa infections and a better understanding of
their route(s) of transmission in operational sat-
uration diving systems, rapid and sensitive tools
for detection of the genotypes involved in infec-
tions are of crucial importance. This study des-
cribes the development of a PCR-based assay for
detection of P. aeruginosa genotype D in occupa-
tional diving environments, as well as for the
identification of P. aeruginosa in general. Ran-
domly amplified polymorphic DNA (RAPD)-PCR
analysis was used to verify the PFGE genotypes
identified previously and formed the basis for the
design of the new PCR assay.
MATERIALS AND METHODS
Bacteria and samples
A group of P. aeruginosa isolates, related to saturation diving in
the Norwegian sector of the North Sea, was selected on the
basis of their PFGE genotypes [2–5]. The isolates comprised 28
genotypes with different origins, persistence and frequencies
of occurrence in infections. Additional P. aeruginosa isolates
from the North Sea, hospitals and the general community, as
well as reference strains for P. aeruginosa, other Pseudomonas
spp. and other bacterial genera, were also included in the
study (Table 1). Sampling, cultivation and biotyping of the
Table 1. Bacterial isolates used in the study
Isolates
Pseudomonas aeruginosa genotypesa
AD AE AL AU BM D E G N P TP1 TP2 TP4 TP5 TP12 TP27 Othersb NT No. of isolates
Diving
Infectionsc 5 1 2 2 6 4 1 1 5 1 1 4 16 49
Environmentd 4 1 2 1 9 9 3 1 2 3 2 2 1 5 3 3 51
Hospital
Infections
Sepsis Strains 1–9 rDN, rEN, rDS, rDO, rEO, rEP, rEQ, rEM, rDH 9
Ear Strains R1-R3 rBB, rBC, rBG 3
Environment Strain R4 rCE 1
‘Snøgg’e xCCV 1
Environment
Freshwater onshore Strains K1, K2 kCCZ, kDaA 2
Reference strains
CCUG 551 T ER
ATCC 27853 BBU
PAO 1 aCB
PA 103 aCC
PAK aCA
388 aCD
PAKS 1 BBD
Non-Pseudomonas aeruginosa
Pseudomonas mendocina CCUG 1781 T Sphingomonas paucimobilis CCUG 6518 T
Pseudomonas stutzeri CCUG 11256 T Brevundimonas diminuta CCUG 1427 T
Pseudomonas alcaligenes CCUG 1425 A T Acinetobacter lwoffii CCUG 33984 T
Pseudomonas fluorescens CCUG 1253 T Acinetobacter baumannii Own isolate
Serratia fonticola CCUG 14186 T Escherichia coli Own isolate
Serratia marcescens CCUG 1647 T Proteus mirabilis Own isolate
Stenotrophomonas maltophilia CCUG 5866 T Klebsiella pneumoniae Own isolate
Comamonas aquatica CCUG 15845 T
T, type strain; CCUG, culture collection of University of Gothenburg; ATCC, American type culture collection; NT, non-typeable by PFGE (five RAPD-PCR genotypes).
aDesignation according to PFGE profiles.
bSingle genotypes: A, AY, J, TP13, TP28, V, AAY.
cSkin infections: external otitis, folliculitis, skin abscess, mostly localised in the face and neck areas.
dIsolates from freshwater, seawater, chamber interiors and divers’ personal equipment.
e‘Snøgg’, a strain from a large hospital outbreak of infection in Norway.
PFGE, pulsed-field gel electrophoresis; RAPD, random amplified polymorphic DNA.
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new isolates were performed by conventional microbiological
and biochemical methods [2,5].
PFGE analysis
PFGE analysis of the new isolates was performed as described
previously [2,3] with rare-cutting endonuclease SpeI (Roche
Diagnostics, Mannheim, Germany).
Preparation of genomic DNA, DNA mixtures and bacterial
lysates
Overnight bacterial cultures grown on Luria broth (LB) were
used for DNA extraction. Genomic DNA was isolated with a
Genomic Prep Cells and Tissue DNA Isolation Kit (Amersham
Biosciences, Uppsala, Sweden), used according to the manu-
facturer’s instructions. DNA concentrations were determined
with a Hoefer DyNA Quant 200 Fluorometer (Amersham
Pharmacia Biotech, Chalfont St Giles, UK). DNA templates
were diluted to a concentration of 5 ng ⁄ lL and stored at
) 20C.
DNA mixtures were prepared with 30 ng DNA of each
strain involved, as follows: mixture 1, Serratia fonticola CCUG
14186 T, Serratia marcescens CCUG 1647 T, Stenotrophomonas
maltophilia CCUG 5866 T, Acinetobacter lwoffii CCUG 33984 T,
Brevundimonas diminuta CCUG 1427 T, Comamonas aquatica
CCUG 15845 T and Sphingomonas paucimobilis CCUG 6518 T;
mixture 2, P. aeruginosa ATCC 27853, P. aeruginosa isolates
belonging to genotypes E, A, N and G (one strain of each),
isolates of Escherichia coli and Proteus mirabilis; mixture 3,
P. aeruginosa CCUG 551 T, P. aeruginosa ATCC 27853, Pseudo-
monas mendocina CCUG 1781 T, Pseudomonas stutzeri CCUG
11256 T, Pseudomonas alcaligenes CCUG 1425 A T, Pseudomonas
fluorescens CCUG 1253 T and a P. aeruginosa isolate belonging to
genotype D; mixture 4, as mixture 3, but without the P. aeru-
ginosa isolate belonging to genotype D; mixture 5, similar to
mixture 1, but with P. mendocina CCUG 1781 T and P. stutzeri
CCUG 11256 T added, and without B. diminuta CCUG 1427 T.
Cultures of single P. aeruginosa strains grown overnight on
blood agar were used for the preparation of bacterial lysates.
Cells were suspended in molecular biology grade water
(Eppendorf, Hamburg, Germany) and boiled for 10 min.
Lysates were prepared similarly from bacterial material
gathered after filtration of water samples and cultivation of
the filters on Pseudomonas agar for 48 h.
RAPD-PCR analysis
RAPD-PCR fingerprints were generated using a Ready-To-
Go RAPD Analysis Beads Kit (Amersham Biosciences)
according to the manufacturer’s guidelines, with slight
modifications. In brief, the PCRs were performed in 25-lL
volumes using 10 ng template DNA and 25 pmol RAPD
analysis primer 1, supplied with the kit. Amplifications were
performed in a Mastercycler gradient thermocycler (Eppen-
dorf), with the cycling parameters recommended by the
manufacturer’s guidelines. A final extension at 72C for
7 min was added. As a control for the PCR, two DNA
samples supplied with the kit (E. coli BL21(DE3) and E. coli
C1a) were amplified in every experiment with RAPD
analysis primer 2. In addition, one or two internal control
DNAs (from PFGE genotype D and ⁄ or E) were included
repeatedly in the analyses.
Fragment extraction and cloning of RAPD-PCR fragments
Fragments from the RAPD-PCR profiles were extracted with a
Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany) and
cloned using a TOPO TA cloning kit for sequencing (Invitro-
gen, Carlsbad, CA, USA) according to the recommendations of
the suppliers. The plasmids from the selected clones were
isolated with a Plasmid Miniprep Kit (Bio-Rad, Hercules, CA,
USA).
Primer design
Following comparison of the sequences of the cloned frag-
ments, Oligo Primer Analysis software (National Biosciences,
Plymouth, MN, USA) was used for primer design. The two
new primer sets were: (a) for P. aeruginosa genotype D:
forward primer DspesUp (5¢-GGGAAAGGGAATGCGGT-
AGA-3¢) and reverse primer DspesLow (5¢-CCACTTGCCT-
GGTTCACCTG-3¢), yielding a 382-bp PCR product; and (b) for
P. aeruginosa in general: forward primer P.a.26Up (5¢-CA-
AGCAATTCGGTTGGATAT-3¢) and reverse primer Ps.fell-
Low (5¢-GGCGTTGAGCTAACCAGTAC-3¢), yielding a 192-bp
PCR product.
PCR amplification with the newly designed PCR primer sets
Amplification reactions were performed in 50-lL mixtures that
contained 1 · Taq Buffer with 1.5 mM Mg2+, dNTPs (50 lM
each), 2 U Taq polymerase (Eppendorf); each primer (synthe-
sised by Eurogentec, Ougre´e, Belgium) 4 ng ⁄ lL, 15 ng tem-
plate DNA and sterile molecular biology grade water. In the
experiments with bacterial lysates, 3 lL of a lysate was used in
the reaction. Multiplex PCR was performed using similar
conditions. Amplifications were carried out in a pre-heated
thermal cycler at 94C for 2 min, followed by 30 cycles of 94C
for 30 s, 65C for 30 s and 72C for 1 min, followed by a final
extension at 72C for 10 min. In every reaction, one or two
DNA samples were included as positive controls, together
with one negative control.
Gel electrophoresis
Aliquots (5 lL) of the RAPD-PCR fragments were separated in
ethidium bromide-stained agarose 2% w ⁄v gels in 1 · TBE
buffer (50 mM Tris, 50 mM boric acid, 1 mM Na2EDTA.2H2O,
pH 8.3) at 7 V ⁄ cm for 150 min. Specific PCR fragments (10-lL
aliquots) were analysed on agarose 1.5% w ⁄v gels in 1 · TBE
buffer at 7 V ⁄ cm for 1–2 h. The 100-bp PCR molecular ruler
and 100-bp molecular ruler (Bio-Rad) were used as molecular
size standards.
The amplification products were photographed under UV
transillumination and analysed visually.
Sequencing of RAPD-PCR fragments and specific PCR
products
Sequencing of RAPD-PCR fragments was performed on an ABI
Prism 310 sequencer (Applied Biosystems, Foster City, CA,
USA) using a BigDye Terminator Cycle Sequencing Kit (Applied
Biosystems) and Primer T3 (Invitrogen). PCR products (382 bp)
from among the genotypes that were amplified by the primer set
for genotype D were also sequenced. These amplification
products were purified with a PCR Purification Kit (Qiagen)
Lødeng et al. PCR assay for detection of P. aeruginosa D genotype 763
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 761–768
and sequenced using the specific primers DspesUp and Dspe-
sLow, and either a BigDye Terminator Cycle Sequencing Kit and
an ABI Prism 310 sequencer, or a CEQ DTCS Start Kit (Beckman
Coulter, Fullerton, CA, USA) and a CEQ 8800 sequencer
(Beckman Coulter). Three amplification products were se-
quenced at least twice to check the reproducibility.
Computer sequence analysis
All the sequences obtained were aligned using the CLU-
STALW program (European Bioinformatics Institute; http://
www.ebi.ac.uk) and compared with the P. aeruginosa PAO1
genome using data from the Pseudomonas Genome Project
(http://www.pseudomonas.com) and the published P. aeru-
ginosa PAO1 genome sequence [13]. A BLAST sequence
alignment search in the GenBank database was also performed
[14].
RESULTS
RAPD-PCR analysis
Analysis of the isolates in this study by RAPD-
PCR showed that the groupings obtained were in
agreement with the PFGE data. Examples of the
RAPD-PCR profiles obtained are shown in Fig. 1.
The analyses revealed fragments ranging from
150 bp to 3000 bp in size, with most of the
amplicons being > 250 bp in size. Nineteen iso-
lates that were non-typeable by PFGE belonged to
five RAPD-PCR genotypes, one of which was
dominant.
Comparisons of the profiles obtained with the
control DNAs analysed in every PCR run showed
reproducible patterns.
Development of PCR primer sets for detection
of P. aeruginosa genotype D and for
P. aeruginosa in general
Two random fragments from the RAPD-PCR
profiles, c.750 bp and 320 bp in size, were con-
sidered to be a potential source for the design of
specific primers. The 750-bp fragment was found
to be characteristic for only a few P. aeruginosa
genotypes (including genotypes D and E), while
the 320-bp fragment was common to all
P. aeruginosa isolates, but absent from the profiles
generated by strains belonging to other species
(Fig. 1). The 750-bp and 320-bp fragments were
extracted and sequenced from two genotype D
isolates (D1 and D10) and two genotype E isolates
(E1 and E4). The 750-bp fragment generated from
an isolate of Klebsiella spp. was also analysed as a
representative of another species.
Sequencing and alignment of the 750-bp frag-
ments demonstrated that the sequences from D1
and D10 were almost identical for a 415-bp region
(only five mismatches), and were different from
the sequences of isolates E1 and E4 and the
Klebsiella spp. The D1 and D10 sequences formed
the basis for the design of a primer set for
detection of P. aeruginosa genotype D. Compar-
ison of the sequences of the D-specific PCR
products with the P. aeruginosa PAO1 genome
showed that the new primer set targets a
sequence that is partly homologous to a gene in
the PAO1 genome encoding a hypothetical class 4
protein (106 bp of 382 bp).
Sequencing and alignment of the sequences
obtained from the 320-bp fragments of the four
P. aeruginosa isolates showed only five mismat-
ches in a 239-bp region. On the basis of this
alignment, a primer set capable of detecting the
species P. aeruginosa was designed. Comparison
with the P. aeruginosa PAO1 genome indicated
that the species-specific primer set amplifies a
sequence that is complementary to the ends of 23S
and 5S rDNA and the 23S-5S intergenic spacer.
The BLAST search for primer target sequence
homologies with the available sequence data in
the GenBank database showed a perfect match
(20 bp ⁄ 20 bp) for DspesLow- and P.a.26Up-pri-
mer sequences only with sequences from P.
Fig. 1. Examples of RAPD-PCR analysis of Pseudomonas
aeruginosa and other bacteria. Lanes: 2, 8, 14 and 19, 100-bp
PCR molecular ruler; 1, Escherichia coli BL 21(DE3) control
DNA; 20, E. coli C1a control DNA; 3, P. aeruginosa D1; 4, P.
aeruginosa D2; 5, P. aeruginosa D10; 6, P. aeruginosa E1; 7, P.
aeruginosa E4; 9, P. aeruginosa TP2-1; 10, P. aeruginosa TP2-2;
11, P. aeruginosa TP12-1; 12, P. aeruginosa TP12-2; 13, P.
aeruginosa PAK; 15, Acinetobacter baumannii; 16, E. coli; 17,
Klebsiella pneumoniae; 18, Proteus mirabilis.
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aeruginosa PAO1. No perfect matching sequence
was found for primer DspesUp, while primer
Ps.fellLow matched perfectly with P. aeruginosa
sequences and a genomic sequence from an
uncultured bacterium 463 (accession number
AY458641). When combined, the species-specific
primers for P. aeruginosa recognised only P.
aeruginosa PAO1 from among the available
sequences in the GenBank database. None of
the sequences in this database could be recog-
nised simultaneously with both primers for
P. aeruginosa genotype D.
Evaluation of the sensitivity, specificity and
applicability of the new PCR assay
The two primer sets were tested on all the isolates
listed in Table 1. The analyses were performed on
single isolates and on mixtures of isolates. Extrac-
ted DNA samples and bacterial lysates were used
as templates for the PCR assays.
Extracted DNA samples and lysates from single
bacterial isolates. In total, 27 (19.6%) of 138 isolates
gave a 382-bp product with the primer set for
P. aeruginosa genotype D. Of 28 PFGE genotypes
related to saturation diving, three were detected
with the PCR. The assay recognised all 15 of the
genotype D isolates, as well as all the isolates
belonging to the TP2 and TP27 genotypes (four
and five, respectively). The PCR was also positive
with three isolates of non-diving origin: one from
a hospital environment (R4) and two (designated
as 3 and 9) from hospitalised patients with sepsis.
Fig. 2(A) shows examples of amplification with
the D genotype primer set. A weak band with a
molecular size comparable to the genotype-speci-
fic PCR product was observed for one E. coli
isolate (lane 16), but extended electrophoresis
showed significant differences in size and
intensity.
The primer set specific for P. aeruginosa recog-
nised all 123 of the P. aeruginosa isolates included
in this study, but none of the isolates belonging to
other genera and species. Fig. 2(B) shows exam-
ples of PCR amplification using the primer set
specific for P. aeruginosa.
The results of the parallel experiments for
PCR amplification of 16 P. aeruginosa isolates
using extracted DNA and bacterial lysates of the
same isolates as templates were in complete
agreement.
Composed DNA mixtures and mixtures with
unknown composition of bacteria. All five mixtures
of DNA were used as templates in PCR assays
with the two new primer sets. The results dem-
onstrated 100% recognition of the presence of
isolates belonging to P. aeruginosa genotype D and
P. aeruginosa, respectively.
Multiplex PCR for simultaneous detection of
P. aeruginosa and genotype D was used with the
lysates of mixtures of bacterial species originating
from seven saturation-related freshwater samples.
The results (Fig. 3) demonstrate that three of the
samples were positive for both primer sets, while
two samples were positive only for P. aeruginosa.
A very weak amplification product was obtained
for P. aeruginosa in sample 2, which may have been
caused by a low concentration of P. aeruginosa in the
sample.
Classical isolation and genotyping (PFGE) of
single colonies from the same samples were also
performed. The presence of P. aeruginosa was
detected in samples 1, 2, 5, 6 and 7, and the TP2
genotype was detected in samples 5 and 7.
None of the expected genotypes was detected in
sample 6.
Fig. 2. Examples of PCR amplification of Pseudomonas
aeruginosa and other bacteria with the two primer sets:
(A) PCR products obtained with the primer set specific for
P. aeruginosa genotype D (382-bp amplicon); (B) PCR
products obtained with the primer set specific for P. aeru-
ginosa (192-bp amplicon). Lanes: 1 and 20, 100-bp molecu-
lar ruler; 2, P. aeruginosa ATCC 27853; 3, P. aeruginosa
CCUG 551 T; 4, P. aeruginosa PAO1; 5, P. aeruginosa D1; 6,
P. aeruginosa TP2-1; 7, Pseudomonas mendocina CCUG 1781
T; 8, Pseudomonas stutzeri CCUG 11256 T; 9, Pseudomonas
fluorescens CCUG 1253 T; 10, Pseudomonas alcaligenes CCUG
1425 A T; 11, Sphingomonas paucimobilis CCUG 6518 T; 12,
Serratia marcescens CCUG 1647 T; 13, Stenotrophomonas
maltophilia CCUG 5866 T; 14, Acinetobacter lwoffii CCUG
33984 T; 15, Comamonas aquatica CCUG 15845 T; 16,
Escherichia coli; 17, Serratia fonticola CCUG 14186 T; 18,
Proteus mirabilis; 19, negative control (no DNA added).
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Analysis of the 382-bp sequences obtained
using the primer set for genotype D
Sequence alignment of the 382-bp PCR products
from 20 of the isolates revealed only minor
differences. All four sequences from strains with
a TP2 genotype had one deletion (at position 84
from the beginning of the forward primer) in
comparison with the other sequences. The ampli-
fication products from the isolates with a D or
TP27 genotype were identical to each other and to
the sequence from one of the isolates from
patients with sepsis (strain 9). Similarly, the
sequences from the other two hospital-related
isolates (strains 3 and R4) revealed only minor
differences compared with each other and with
the rest of the sequences analysed.
DISCUSSION
This study describes the design of a new
PCR assay for detection of the most frequent
P. aeruginosa genotype (D) encountered in infec-
tions associated with occupational saturation
diving. Together with the species-specific primer
set for P. aeruginosa, the new assay has the
potential to be a powerful tool for early detection
and prevention of P. aeruginosa infections in this
specific niche.
Various strategies have been employed previ-
ously to develop primer sets and probes for rapid
detection and identification of bacteria. In the
present study, random genomic sequences were
chosen to develop the PCR assay. Subsequent
analyses showed that the random sequence used
to design the primer set for P. aeruginosa genotype
D corresponds, in part, to a sequence in the PAO1
genome coding for a hypothetical class 4 protein
[13].
The assay for detection of genotype D was
tested with 100 isolates related to diving, and two
additional diving-related PFGE genotypes (TP2
and TP27) were recognised. The TP2 genotype has
persisted in diving systems for 3 years, and there
are indications of its high frequency of occurrence
in infections during this period (personal unpub-
lished data). Little is known concerning the TP27
genotype, as it has not been recorded previously.
The five TP27 isolates in the present study, all of
which originated from freshwater samples, were
isolated on a single occasion. The absence of data
for these two genotypes, as well as for the target
of the primer set discussed here, makes it imposs-
ible at this stage to determine the precise reason
for their occurrence, apart from noting that these
genotypes are related genetically to genotype D.
To evaluate the potential of the new PCR assay,
P. aeruginosa isolates from hospitals and other
environments were also included in the study.
Three hospital-related isolates (two from infec-
tions and one from the hospital environment)
were recognised, indicating a potential for the
assay beyond the diving niche. However, the
main aim of the present study was to develop a
rapid method capable of detecting the P. aerugi-
nosa D genotype in diving-related microbial
material containing an unknown bacterial popu-
lation. As the North Sea diving environment
contains an abundance of microbial species, the
possibility that the primer set for the D genotype
might amplify a fragment of the same size from
another identified or unidentified species cannot
be excluded. For this reason, parallel recognition
of P. aeruginosa at the species level would streng-
then the specificity of the new PCR assay.
Many diagnostic PCR assays and oligonucleo-
tide probes for P. aeruginosa and Pseudomonas spp.
target genes for 16S rRNA [15–18] and 16S-23S
intergenic spacers [19,20], as well as other specific
genes [21–27]. In the present study, the primer set
amplified the intergenic spacer region between
Fig. 3. Amplicons generated from lysates of bacterial
mixtures originating from freshwater samples from the
diving environment following multiplex PCR with primer
sets for Pseudomonas aeruginosa and P. aeruginosa genotype
D. Lanes: 1, 100-bp molecular ruler; 2, P. aeruginosa D5 –
extracted DNA (positive control); 3, sample 1; 4, sample 2;
5, sample 3; 6, sample 4; 7, sample 5; 8, sample 6; 9, sample
7; 10, negative control (no DNA added).
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the 23S and 5S rDNA genes. PCR assays for P.
aeruginosa that amplify the 23S-5S rDNA spacer
have not been reported previously. However, the
paucity of sequence data in this region for non-P.
aeruginosa strains makes any theoretical predic-
tion of its specificity difficult. The Pseudomonas
genus has a complex taxonomy, and a reassess-
ment of the phylogenetic affiliation of the pseu-
domonads has been published [28]. In the present
study, 123 P. aeruginosa isolates, four other pseu-
domonads and 11 representatives of other a-, b-
and mostly c-Proteobacteria were investigated.
The primer set was capable of recognising all the
P. aeruginosa isolates studied, and showed poten-
tial when it was applied to mixtures of bacterial
strains. The theoretical match with available
sequences in GenBank also pointed to high
specificity. However, further evaluation of the
specificity by testing species that are closely
related phylogenetically to P. aeruginosa is neces-
sary.
The time required to complete the analysis was
reduced by eliminating the need to isolate single
colonies from the diving-related microbial mater-
ial and extract DNA. A further reduction could be
achieved by the use of multiplex PCR. In this
connection, the assay was tested with bacterial
DNA mixtures of relevance to the diving envi-
ronment to check for possible interference in the
PCR. Multiplex PCR was also performed on
lysates from diving-related microbial material
with an unknown bacterial composition. The fact
that it was not possible to isolate any of the target
P. aeruginosa genotypes from one of the PCR-
positive samples (sample 6) does not exclude the
possibility that they were present in the bacterial
mixture. This can be explained by a high level of
biodiversity among the strains belonging to this
species, and the limitations of culture methods for
isolation [29].
In conclusion, a rapid detection assay was
developed for the P. aeruginosa genotype (D) that
occurs most frequently in skin infections among
occupational saturation divers, as well as for
rapid detection of P. aeruginosa in general.
Although further evaluation of the specificity
and applicability of the method is necessary, the
results suggest that the PCR assay described in
the present study may contribute to early detec-
tion of infection and the initiation of suitable
treatment. Combined with other molecular typ-
ing methods, the assay could be a useful tool for
the effective control of reservoirs, sources and
spread of infection, thus improving prevention
strategies.
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